Response to antiviral treatment in patients with HCV cryoglobulinemia vasculitis after 3 months of treatment. Patients who died are compared with surviving patients at the end of the study.
| Response at Month 3 (%) | Surviving Patients (n = 63) | Patients Who Died (n = 23) | Hazard Ratio (95% CI) | p |
|---|---|---|---|---|
| Clinical | 21 (33.9) | 2 (8.7) | 0.28 (0.06–1.19) | NS |
| Virological | 38 (61.3) | 7 (30.4) | 0.39 (0.16–0.95) | 0.04 |
| Immunological | 20 (32.3) | 6 (26.1) | 0.99 (0.38–2.56) | NS |
HCV: hepatitis C virus; NS: not significant.